Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging.


Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 Feb 2022
Historique:
pubmed: 28 7 2021
medline: 16 3 2022
entrez: 27 7 2021
Statut: ppublish

Résumé

To identify the association between insomnia symptoms and signs of prodromal neurodegeneration, including an analysis of potential differences between sleep-onset and sleep-maintenance insomnia. We included those aged 45-85 years, living in 1 of 10 Canadian provinces between 2012 and 2015 (at the baseline), recruited via 3 population-based sampling methods. Insomnia symptoms were assessed using questions adapted/modified from the Pittsburgh Sleep Quality Index. A panel of potential prodromal neurodegenerative markers including self-reported symptoms and objective gait motor, cognitive, and autonomic variables were assessed cross sectionally. We compared those who endorsed insomnia symptoms ≥ 3 times per week to controls, adjusting for age, sex, and education via logistic regression. Overall, 2,051/30,097 people screened positive for sleep-onset insomnia alone and 4,333 for sleep-maintenance insomnia alone, while 2,371 endorsed both subtypes. On objective gait tests, participants with sleep-onset insomnia, but not sleep-maintenance insomnia, had worse balance (odds ratio [OR] = 1.33, 95% confidence interval = [1.16, 1.52]) and slower gait speed (OR = 1.52 [1.34, 1.73]). Although participants with any insomnia subtype endorsed more motor symptoms, these were more severe in those with sleep-onset insomnia (OR onset vs maintenance = 1.13 [1.07, 1.18]). On objective cognitive tests, those with sleep-maintenance insomnia scored normally. However, participants with sleep-onset insomnia performed worse on tests of verbal fluency (OR = 1.24 [1.06, 1.43]), immediate memory (OR = 1.23 [1.08, 1.41]), and prospective memory task (OR = 1.29 [1.11, 1.50]). The sleep-onset insomnia group also had lower heart rate variability (OR = 1.23 [1.07, 1.43]). Secondary analyses found generally similar results in young vs older age of insomnia development. Compared to maintenance insomnia, those with sleep-onset insomnia have more motor, cognitive, and autonomic signs/symptoms. When evaluating neurodegenerative risk, differentiating insomnia subtypes may increase precision. Yao CW, Pelletier A, Fereshtehnejad S-M, Cross N, Dang-Vu T, Postuma RB. Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging.

Identifiants

pubmed: 34314348
pii: jcsm.9562
doi: 10.5664/jcsm.9562
pmc: PMC8804990
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-359

Subventions

Organisme : CIHR
ID : MOP 142191
Pays : Canada
Organisme : CIHR
ID : PJT 153115
Pays : Canada
Organisme : CIHR
ID : PJT 156125
Pays : Canada
Organisme : CIHR
ID : PJT 166167
Pays : Canada
Organisme : CIHR
ID : LSA 94473
Pays : Canada
Organisme : CIHR
ID : ACD 151284
Pays : Canada

Informations de copyright

© 2022 American Academy of Sleep Medicine.

Références

Curr Alzheimer Res. 2018;15(1):80-88
pubmed: 28558638
Neurology. 2020 Oct 6;95(14):e1963-e1970
pubmed: 32817390
NPJ Parkinsons Dis. 2017 Mar 20;3:9
pubmed: 28649609
Mov Disord. 2012 Jun;27(7):913-6
pubmed: 22729987
BMC Psychiatry. 2018 Feb 7;18(1):38
pubmed: 29415688
Front Neurosci. 2019 Jul 09;13:710
pubmed: 31354419
Front Public Health. 2017 Sep 28;5:258
pubmed: 29034226
J Am Coll Nutr. 2008 Aug;27(4):492-8
pubmed: 18978169
J Stroke. 2018 Jan;20(1):12-32
pubmed: 29402071
Arch Neurol. 2006 Dec;63(12):1763-9
pubmed: 17172617
Sleep. 2017 Jan 01;40(1):
pubmed: 28364450
Sleep. 2012 Sep 01;35(9):1201-7
pubmed: 22942498
Stroke. 2012 Jan;43(1):32-7
pubmed: 22020036
Nihon Rinsho. 2015 Jun;73(6):916-23
pubmed: 26065120
Sleep Med Rev. 2019 Dec;48:101215
pubmed: 31630016
Eur J Prev Cardiol. 2014 Jan;21(1):57-64
pubmed: 22942213
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Sleep Med Rev. 2002 Apr;6(2):97-111
pubmed: 12531146
Arch Med Sci. 2010 Mar 1;6(1):11-8
pubmed: 22371714
Neurology. 2017 Jan 24;88(4):352-358
pubmed: 27986876
Sleep. 2019 Aug 1;42(8):
pubmed: 31089710
Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1117-1131
pubmed: 28777179
PLoS One. 2012;7(11):e49113
pubmed: 23145088
J Am Geriatr Soc. 2001 Dec;49(12):1628-32
pubmed: 11843995
Menopause. 2020 Mar;27(3):295-304
pubmed: 31851117
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35
pubmed: 12438461
Cortex. 2006 Apr;42(3):347-55
pubmed: 16771040
Med Sci (Basel). 2018 Jun 21;6(3):
pubmed: 29933646
Aging Ment Health. 2020 Sep;24(9):1466-1471
pubmed: 31791142
Can J Aging. 2009 Sep;28(3):221-9
pubmed: 19860977
Chest. 2017 Aug;152(2):435-444
pubmed: 28153671
Lancet Neurol. 2015 Jan;14(1):57-64
pubmed: 25435387
Alzheimers Dement. 2015 Sep;11(9):1090-7
pubmed: 25438949
Int J Epidemiol. 2021 Jul 9;50(3):817-828
pubmed: 33150399
J Clin Exp Neuropsychol. 1997 Feb;19(1):52-62
pubmed: 9071641
Int Psychogeriatr. 2018 Feb;30(2):185-196
pubmed: 28899446
Expert Rev Neurother. 2011 May;11(5):665-76
pubmed: 21539487
J Am Geriatr Soc. 2011 Mar;59(3):559-62
pubmed: 21391952
Neurology. 2018 Dec 26;:
pubmed: 30587514
Arch Clin Neuropsychol. 2007 Nov;22(8):925-31
pubmed: 17681741
J Sleep Res. 2017 Oct;26(5):623-628
pubmed: 28470725
Brain. 2019 Jul 1;142(7):2051-2067
pubmed: 31111143
Front Neurol. 2017 Feb 16;8:42
pubmed: 28261151
Sleep Med Rev. 2019 Feb;43:96-105
pubmed: 30537570
Am J Geriatr Psychiatry. 2015 Jun;23(6):651-4
pubmed: 25794635
Sleep Med Rev. 2018 Aug;40:4-16
pubmed: 28890168
Am J Cardiol. 2016 Aug 15;118(4):511-9
pubmed: 27324160

Auteurs

Chun W Yao (CW)

Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada.
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Amélie Pelletier (A)

Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Research Center of the Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.

Seyed-Mohammad Fereshtehnejad (SM)

Division of Neurology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Nathan Cross (N)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
PERFORM Centre, Center for Studies in Behavioral Neurobiology, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, Quebec, Canada.

Thanh Dang-Vu (T)

Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
PERFORM Centre, Center for Studies in Behavioral Neurobiology, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, Quebec, Canada.

Ronald B Postuma (RB)

Research Center of the Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH